Article
Biochemistry & Molecular Biology
Jun Ogata, Kentaro Hirao, Kenya Nishioka, Arisa Hayashida, Yuanzhe Li, Hiroyo Yoshino, Soichiro Shimizu, Nobutaka Hattori, Yuzuru Imai
Summary: A novel LRRK2 variant-p.G2294R located in the WD40 domain was detected in a patient with familial Parkinson's disease through targeted gene-panel screening. This variant was found to be highly destabilized at the protein level. Experimental results showed upregulated expression of the LRRK2 p.G2294R protein in the patient's peripheral blood lymphocytes, while macrophages differentiated from the same blood sample exhibited decreased levels of LRRK2 protein. Additionally, reduced phagocytic activity was observed in pathogenic yeasts and alpha-synuclein fibrils.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Biochemistry & Molecular Biology
Vinita G. Chittoor-Vinod, R. Jeremy Nichols, Birgitt Schule
Summary: Missense mutations in the LRRK2 gene are a pathogenic cause of Parkinson's disease, with approximately 100,000 individuals worldwide carrying the risk variant. Clinical presentation of LRRK2 parkinsonism is similar to sporadic PD but varies in disease penetrance and age at onset, with neuropathological features ranging from nigrostriatal loss with Lewy body pathology to atypical neuropathology, including cases of concomitant Alzheimer's pathology.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Clinical Neurology
Michael G. Heckman, Catherine Labbe, Ana L. Kolicheski, Alexandra I. Soto-Beasley, Ronald L. Walton, Rebecca R. Valentino, Emily R. Brennan, Patrick W. Johnson, Saurabh Baheti, Vivekananda Sarangi, Yingxue Ren, Ryan J. Uitti, Zbigniew K. Wszolek, Owen A. Ross
Summary: Genome-wide association studies have identified the LRRK2 gene as a susceptibility locus for idiopathic Parkinson's disease in Caucasians, with variants like rs1491942 and rs76904798 showing strong associations. However, this study did not find a clear causal variant driving the GWAS signal, despite identifying 34 candidate variants that may influence LRRK2 GWAS association. Further research and functional studies are needed to definitively assess the causal variants of LRRK2.
PARKINSONISM & RELATED DISORDERS
(2021)
Article
Clinical Neurology
Pei Wang, Peijing Cui, Qi Luo, Jie Chen, Huidong Tang, Lina Zhang, Shengdi Chen, Jianfang Ma
Summary: The penetrance of the G2385R variant in the Chinese population was found to be 25.9%.
EUROPEAN JOURNAL OF NEUROLOGY
(2022)
Article
Cell Biology
Joanne Toh, Ling Ling Chua, Patrick Ho, Edwin Sandanaraj, Carol Tang, Hongyan Wang, Eng King Tan
Summary: This study demonstrates the neuroprotective effects of LRRK2 protective variants in a Parkinson's disease fruit fly model. RNA sequencing revealed upregulation of specific gene pathways in flies carrying the pathogenic variant, which was restored in rescue phenotypes. Using protective gene variants may offer potential new therapeutic targets for aging and neurodegeneration in PD.
Article
Clinical Neurology
Jessica M. Bright, Holly J. Carlisle, Alyssa M. A. Toda, Molly Murphy, Tyler P. Molitor, Paul Wren, Kristin M. Andruska, Enchi Liu, Carrolee Barlow
Summary: The study found that a G2019S LRRK2 selective inhibitor can effectively reduce phosphorylated biomarkers of mutant G2019S LRRK2 while protecting the normal LRRK2. This precision medicine treatment paves the way for treating G2019S LRRK2 PD.
MOVEMENT DISORDERS
(2021)
Article
Cell Biology
Milena Fais, Giovanna Sanna, Manuela Galioto, Thi Thanh Duyen Nguyen, Mai Uyen Thi Tran, Paola Sini, Franco Carta, Franco Turrini, Yulan Xiong, Ted M. Dawson, Valina L. Dawson, Claudia Crosio, Ciro Iaccarino
Summary: LRRK2 mutations are crucial in both familial and sporadic Parkinson's disease and its interaction with the exocyst complex subunit Sec8 points to a potential role in regulating vesicle trafficking in neurons. This suggests a novel molecular mechanism for LRRK2 in modulating vesicle trafficking and highlights the complexity of its function in neuronal physiology.
Article
Neurosciences
Isabella Russo, Luigi Bubacco, Elisa Greggio
Summary: This review summarizes the role of LRRK2 in modulating central and peripheral inflammation in Parkinson's disease and inflammatory disease models. In addition, it discusses the potential benefits of LRRK2 inhibitors and anti-inflammatory drugs in reducing disease risk and progression.
NEUROBIOLOGY OF DISEASE
(2022)
Article
Cell Biology
Yaiza Corral Nieto, Sokhna M. S. Yakhine-Diop, Paula Moreno-Cruz, Laura Manrique Garcia, Amanda Gabrielly Pereira, Jose A. Morales-Garcia, Mireia Niso-Santano, Rosa A. Gonzalez-Polo, Elisabet Uribe-Carretero, Sylvere Durand, Maria Chiara Maiuri, Marta Paredes-Barquero, Eva Alegre-Cortes, Saray Canales-Cortes, Adolfo Lopez de Munain, Jordi Perez-Tur, Ana Perez-Castillo, Guido Kroemer, Jose M. Fuentes, Jose M. Bravo-San Pedro
Summary: Using mass spectrometry, this study identified metabolic changes in the liver of mouse models of Parkinson's disease, with the aim of finding new peripheral biomarkers for diagnosis.
Article
Clinical Neurology
P. Prendes Fernandez, M. Blazquez Estrada, J. Sol Alvarez, V. Alvarez Martinez, E. Suarez San Martin, C. Garcia Fernandez, J. C. Alvarez Carriles, B. Lozano Aragoneses, A. Saiz Ayala, E. Santamarta Liebana, L. Gonzalez Alvarez
Summary: This study compared the clinical and pharmacological response to subthalamic nucleus deep brain stimulation (STN-DBS) between patients with monogenic forms of Parkinson's disease (PD) and non-mutation carriers with idiopathic PD. The results showed no significant differences between the two groups, indicating that the effectiveness of STN-DBS is similar in patients with genetic mutations and those with idiopathic PD.
PARKINSONISM & RELATED DISORDERS
(2023)
Article
Neurosciences
Lucia Batzu, Daniele Urso, Michel J. Grothe, Daniel Vereb, K. Ray Chaudhuri, Joana B. Pereira
Summary: It has been suggested that LRRK2 mutations in Parkinson's disease (PD) are associated with a more benign clinical phenotype and preserved cholinergic function. This study compared basal forebrain (BF) volumes in LRRK2 carriers with and without PD with respect to idiopathic PD (iPD) patients and controls. The results showed that LRRK2-PD patients and asymptomatic LRRK2 carriers had significantly higher BF volumes compared to iPD patients and controls. BF volumes predicted cognitive decline in iPD patients but not in LRRK2-PD patients, suggesting a potential compensatory mechanism in LRRK2-PD.
NEUROBIOLOGY OF DISEASE
(2023)
Review
Genetics & Heredity
Eun-Mi Hur, Byoung Dae Lee
Summary: Parkinson's disease is a heterogeneous neurodegenerative disease characterized by the loss of dopaminergic neurons and the formation of proteinaceous inclusions. Aging is considered a major risk factor influencing the progression of PD, with common changes in cellular functions shared by aging and PD. Mutations in the LRRK2 gene are a common genetic cause of both familial and sporadic PD, and may interact with aging to contribute to PD pathologies.
Article
Chemistry, Medicinal
Albert W. Garofalo, Jacob Schwarz, Kerry Zobel, Claudia Beato, Silvia Bernardi, Federica Budassi, Laura Caberlotto, Peng Gao, Cristiana Griffante, Xinying Liu, Marco Migliore, Feifei Qiao, Fabio Maria Sabbatini, Anna Sava, Mingliang Zhang, Holly J. Carlisle
Summary: The G2019S variant of LRRK2 is associated with Parkinson's disease (PD) and causes an increase in kinase activity. A series of novel kinase inhibitors have been discovered that selectively inhibit the phosphorylation of LRRK2 in the mouse brain, offering potential for precision medicine in future PD therapeutics.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2023)
Article
Neurosciences
Linn Streubel-Gallasch, Veronica Giusti, Michele Sandre, Isabella Tessari, Nicoletta Plotegher, Elena Giusto, Anna Masato, Ludovica Iovino, Ilaria Battisti, Giorgio Arrigoni, Derya Shimshek, Elisa Greggio, Marie-Eve Tremblay, Luigi Bubacco, Anna Erlandsson, Laura Civiero
Summary: This study compared the ability of astrocytes carrying PD-linked gene mutations with normal astrocytes in handling α-synuclein, finding a decreased clearance capacity in mutant cells linked to a loss of function in AnxA2.
MOLECULAR NEUROBIOLOGY
(2021)
Article
Cell Biology
Sokhna M. S. Yakhine-Diop, Mario Rodriguez-Arribas, Saray Canales-Cortes, Guadalupe Martinez-Chacon, Elisabet Uribe-Carretero, Mercedes Blanco-Benitez, Gema Duque-Gonzalez, Marta Paredes-Barquero, Eva Alegre-Cortes, Vicente Climent, Ana Aiastui, Adolfo Lopez de Munain, Jose M. Bravo-San Pedro, Mireia Niso-Santano, Jose M. Fuentes, Rosa A. Gonzalez-Polo
Summary: Autophagy is a cellular mechanism responsible for maintaining internal balance by degrading cellular components, but it can be altered in various diseases, including Parkinson's disease. Parkinson's disease is a multifactorial disease, with mutations in the LRRK2 gene affecting the autophagy mechanism and compromising cell viability.
CELL BIOLOGY AND TOXICOLOGY
(2022)